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ARTICLE
Epigenetic dysregulation of naive CD4+ T-cell
activation genes in childhood food allergy
David Martino 1,2, Melanie Neeland1, Thanh Dang1, Joanna Cobb1, Justine Ellis1, Alice Barnett1, Mimi Tang1,
Peter Vuillermin1,3,4, Katrina Allen1 & Richard Saffery 1
Food allergy poses a signiﬁcant clinical and public health burden affecting 2–10% of infants.
Using integrated DNA methylation and transcriptomic proﬁling, we found that polyclonal
activation of naive CD4+ T cells through the T cell receptor results in poorer lymphoproli-
ferative responses in children with immunoglobulin E (IgE)-mediated food allergy. Reduced
expression of cell cycle-related targets of the E2F and MYC transcription factor networks, and
remodeling of DNA methylation at metabolic (RPTOR, PIK3D, MAPK1, FOXO1) and inﬂam-
matory genes (IL1R, IL18RAP, CD82) underpins this suboptimal response. Infants who fail to
resolve food allergy in later childhood exhibit cumulative increases in epigenetic disruption at
T cell activation genes and poorer lymphoproliferative responses compared to children who
resolved food allergy. Our data indicate epigenetic dysregulation in the early stages of signal
transduction through the T cell receptor complex, and likely reﬂects pathways modiﬁed by
gene–environment interactions in food allergy.
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Immunoglobulin E (IgE)-mediated food allergy has become aprominent problem affecting 2–10% of infants1, and developsfrom a failure in the immunological pathways mediating oral
tolerance during early immune development2. The reason that
this occurs in some individuals is poorly understood, but related
to dysregulation of mucosal immune homeostasis, due to the
inﬂuence of genetic, epigenetic, and environmental factors on
perinatal immune development3–8. Immunological studies reveal
that many aspects of immune development and function are
altered in atopic children and infants with food allergy. Variations
in the frequency and function of peripheral blood cell sub-
populations are detectable at birth in children who subsequently
develop food allergy9, and are related to pro-inﬂammatory neo-
natal immune responses that persist into early infancy10. Atte-
nuated T cell signaling11 and regulatory T cell (Treg)-suppressive
function12 have also been reported among neonates that acquire
food allergies in infancy. These initiating mechanisms reﬂect the
early dysregulation of immune development and likely predispose
to the eventual failure of mucosal networks that mediate oral
tolerance.
Delayed maturation of T cell function is a classical feature of
the atopic phenotype13, and depressed T cell function has been
linked with the induction of allergic diseases14,15, although the
mechanisms are unclear. Recent evidence suggests that this
extends to food allergy16,17, and work from our own group11 and
others9 suggests that suboptimal T cell response capacity to
mitogens and allergens is an important pre-morbid factor in the
development of food allergy. We have previously described dif-
ferences in neonatal total CD4+ T cell activation gene response
capacity and proliferative potential in children who eventually
develop food allergy in the ﬁrst year of life11. These differences
are apparent at birth at an age that is unrelated to allergen
exposure and therefore of unknown clinical signiﬁcance. These
data suggest that T cell activation pathways are potentially
modiﬁed by gene–environment interactions in pregnancy and
early life; however, the speciﬁc gene and pathways underpinning
suboptimal T cell activation have not been deﬁned. It is necessary
to deﬁne a molecular signature of reduced T cell maturation if
future interventions are to be successful. Epigenetics is an
attractive area of research as epigenetic modiﬁcations can be
modiﬁed to change gene expression without altering gene
sequence. Here we extend this work to focus on naive CD4+
T cells, which are mature multipotent precursors with the capa-
city to adopt a range of different T cell effector and memory
phenotypes depending on intracellular signaling factors and
extracellular cytokine cues. After activation, naive CD4+ T cells
establish heritable transcriptional programs that enable progres-
sion to short-lived or long-lived effector/memory phenotypes.
The initial phase of naive CD4+ T cell priming involves epige-
netic remodeling of chromatin that is crucial for mounting
effective immune responses, and inﬂuencing T cell lineage
decisions18.
In this study, we investigate naive CD4+ T cell activation in a
cohort of infants with challenge-conﬁrmed egg allergy, relative to
age-matched non-atopic controls. We use genome-wide DNA
methylation and transcriptional proﬁling to delineate molecular
pathways of naive T cell responsiveness to activation under
neutral (non-differentiating) conditions using bead-bound anti-
CD3/anti-CD28 to polyclonally stimulate the canonical T cell
receptor signaling pathway. We reasoned that activation under
neutral conditions would reveal intrinsic differences in T cell
responsiveness independent of external cytokines and antigen
presentation cues. By proﬁling DNA methylation, gene expres-
sion, and quantitating cell counts and viability pre-activation and
post-activation as a readout of proliferation, we gained insights
into naive T cell responsiveness to activation. We compared these
data between age-matched cases and controls at 12 months of age
(hereafter referred to as baseline) to identify intrinsic differences
in gene regulatory pathways associated with food allergy. These
analyses were repeated at 2 or 4 years of age (hereafter referred to
as follow-up) among the allergic cases, by which time ~60% had
outgrown their food allergy. Our data reveal a molecular pattern
of T cell activation gene dysregulation in infants with food allergy,
associated with poor lymphoproliferative responses.
Results
Characterization of T cell stimulus-responsive pathways. This
study was a retrospective analysis of a prospective birth cohort,
utilizing both cross-sectional and longitudinal factorial design as
outlined in Fig. 1. Characteristics for the subjects selected for this
study are shown in Supplementary Table 1. The allergic group
consisted of slightly more males (50% of cases vs. 43% of con-
trols) and less individuals of parent-reported Caucasian ancestry
(88.6% of cases vs. 95% of controls). The allergic group had a
higher family history of food allergy (18.1% of cases vs. 0%
controls). Children in the control group were more likely to have
attended daycare (29.5% of cases vs. 38% of controls), but the
groups were otherwise homogenous for commonly studied epi-
demiological factors associated with food allergy.
We initially performed an analysis of both the transcriptome
and methylome of quiescent vs. naive T cells activated under
neutral conditions in all individuals at baseline to characterize
pathways associated with T cell activation. In preliminary studies,
we determined that 72 h was an optimal time-point for
methylation studies as this was the maximum time quiescent
naive T cells can rest in culture before substantial culture-induced
changes in DNA methylation are detected in the genome-wide
scans (Supplementary Figure 1). Activation of T cells for 72 h
induced a 2.7-fold expansion compared with un-activated
quiescent cells (median quiescent= 500,000, 95% conﬁdence
interval (CI)= 385,000–700,000, median activated= 1.36 × 106,
95% CI= 850,000–2 × 106, P < 0001), and resulted in the release
of large amounts of interleukin-2 (IL-2) and tumor necrosis
factor-α (TNF-α), with moderate release of IL-10 and interferon-
γ (IFN-γ), with no detectable IL-6 or IL-4 consistent with their
proﬁle as T-helper type 0 (Th0) early effector cells19 (Supple-
mentary Figure 2).
Comparing quiescent vs. T cells activated for 72 h under
neutral conditions revealed considerable stimulus-responsive
changes in gene expression (4154 genes, false discovery rate
Baseline
(12-months)
Follow-up
(2 or 4 years)
1. Characterization of
Stimulus-responsive pathways
2. Cross-sectional analysis of
Allergics v controls
3. Change over time
Quiescent NA
Activated NA
Legend
v
v
Quiescent FA
Activated FA
Fig. 1 Overview of study design and analysis. Clinical assessments occurred
at baseline and the allergic subjects were re-assessed several years later at
follow-up, at which point 59% had resolved allergy. Bloods were collected
at both time points, and frozen for later analysis. Experiments were batched
such that naive CD4+ T cells (baseline and follow-up) were ﬂow sorted
from bloods prior to cell culture and molecular analyses. NA non-allergic,
FA food allergy
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(FDR) ≤0.05 and log fold change ≥1.5, Supplementary Data 1)
and remodeling of DNA methylation (558 CpG dinucleotides,
FDR ≤0.05 and log fold change ≥1.5, Supplementary Data 2)
(Fig. 2a). We used gene sets testing of molecular signatures in the
hallmark collection20 to identify biological pathways enriched
among the stimulus-responsive genes. Consistent with an
activated and highly proliferative state, activated T cells show
increased expression of cell cycle-related targets of the E2F
transcription factor (TF) network that control cell division and
DNA replication, as well as genes regulated by MYC, a proto-
oncogene that acts as a molecular “cell division timer” and
controls metabolic switching after antigen stimulation21 (Table 1).
Among these pathways were cyclins (CCNA1, CCNA2, CCNB1,
CCNB2, CCND2, CCNE1, CCNE2) and cyclin-dependent kinases
(CDK1, CDK2, CDK4, CDK6, CDK7). In accordance with the
metabolic requirement to sustain proliferation, we observed
upregulation of the MTORC1 pathway and genes involved in
glycolysis and fatty acid oxidation. Concomitant with this cell
proliferative and metabolic response was expression of JAK-
STAT signaling molecules induced by IL-2 in response to
activation (CD25, JAK2, CISH, BCL3, STAT1, STAT3, TSLP,
SOCS1–3) as well as upregulation of various cytokines (IFNG,
IFN1B, IL-2, IL-4, IL6ST, IL13, IL21, IL22) and cytokine receptors
(IFNLR1, IL11RA, IL12RB2, IL15RA, IL2RA, IL2RB, IL23R,
IL3RA, IL6R, IL7R, IL9R). The latter is indicative of the transition
from quiescent to effector cell phenotype. The gene expression
proﬁle of activated naive T cells was consistent with an early
effector “Th0” phenotype by virtue of their expression of
characteristic surface markers (OX40L, ICOS, CD25, CD69,
CD154, ICAM1, CD137), and T effector gene proﬁle (KLRG1-
lo, CD27-lo, CCR7-lo, CD62L-lo, CD25-hi, CD69-hi) (Fig. 2b).
Dynamic changes in the DNA methylation landscape following
activation were largely characterized by a widespread loss of DNA
methylation at 510/558 (91.3%) regions associated with 220
unique genes, with a modest gain of methylation observed at 48
(8.7%) CpG sites. Using publicly available chromatin
immunoprecipitation-sequencing (ChIP-seq) data from primary
naive CD4+ T cells, we determined that this widespread loss of
methylation was enriched at active enhancer regions marked by
the H3K4me1 (enrichment score= 6.4, P= 0.004) and, to a lesser
extent, H3K4me3 (enrichment score= 4.1, P= 0.004), H3K27ac
(enrichment score= 3.1, P= 0.04), and H3K36me3 (enrichment
score= 1.9, P= 0.004) marking actively transcribed promoters
and gene bodies, respectively22 (Fig. 2c, statistics in
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Fig. 2 Dynamic remodeling of epigenetic landscape in naive T cells following activation. a Genome-wide view of the –log 10 P value for 4154 differentially
expressed genes (red circles) and 558 differentially methylated CpG (blue circles). b Heatmap of average gene expression (rows) for select genes. Cells
are colored by the level of expression (blue, low; red, high). c Heatmap shows differentially methylated CpGs by genomic location (y-axis) relative to
distance from transcriptional start sites (x-axis). Each panel shows enrichment for speciﬁc histone marks. d Relationship between differential methylation
and gene expression for selected genes. X-axis shows the difference in expression (activated minus quiescent cells) as percent methylation (10−2). Y-axis
shows the log 2 fold change. Points in red were signiﬁcantly differentially methylated and expressed (remodeled genes) at a genome-wide level. Teff: T
effector
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Supplementary Table 2). Integrated analysis of expression and
methylation data sets showed a clear relationship between
differentially methylated CpG sites and changes in gene
expression (Fig. 2d). In many cases, loss of methylation correlated
with upregulation of the expression of the corresponding gene
and vice versa. Generally, changes in gene expression were
modest, although a core set of 59 unique genes were both
differentially methylated and expressed at the genome-wide level
of signiﬁcance, and we refer to these as “differentially remodeled”
(Fig. 2d, points in red). This is consistent with the establishment
of a permissive epigenetic state associated with a shift in stable
gene expression proﬁle. Gene set analysis of this subset of
“remodeled” genes indicated enriched targets of the nuclear factor
of activated T cell TF network (FDR P value= 2.76 × 10−76)
involved in the IL-2-STAT5 signaling pathway (FDR P value=
1.34 × 10−3, IL2RA, RORA, BCL21, GALM), TNFA-NFKB
signaling pathway (FDR P value= 1.34 × 10−3, ATF3, NFKB1,
NR4A3, B4GALT5), and the IFN-γ response (FDR P value=
1.34 × 10−3, NFKB1, CASP7, CD274).
Case–control analysis of allergic infants. We next explored
whether T cell activation-induced changes in the epigenetic and
transcriptional landscape were related to food allergy status in
samples collected at baseline (12-month infants). Unsupervised
principal component (PC) clustering analysis of the 4154 differ-
entially expressed genes, and the 558 differentially methylated loci
revealed clustering according to both T cell activation status
(PC1) and food allergy status (PC2) (Fig. 3a, b). Clustering by
food allergy status was substantially more evident among acti-
vated cells. This suggested that T cell activation gene networks
were at least partially related to food allergy status.
Functional measures of T cell activation also suggested that
food allergic children exhibited an attenuated proliferative
response capacity compared with age-matched non-atopic
counterparts (median non-allergics= 3 × 106, median allergics
= 7 × 105, P < 0.0001, Fig. 4a). This hypo-proliferative response
was not explained by a higher rate of cell death in the allergic
group (Fig. 4a), nor was it explained by differences in the
expression of CD3 at the apical surface prior to activation
(Supplementary Figure 3). Analysis of secreted cytokines
indicated the IL-2 response, which is coupled to T cell receptor
signaling, was intact among allergic individuals arguing against T
cell anergy as a potential explanation. We also noted that there
was evidence for higher number of IL-10 (P exact= 0.0018) and
IFN-γ (P exact= 0.024) responders in the activated cells from
allergics (Fig. 4b).
To further quantify molecular changes associated with food
allergy, we compared genome-wide DNA methylation and gene
expression data sets between allergic cases and non-atopic
controls. In activated T cells, we detected substantial differential
expression at 1412 genes (FDR ≤0.05, Supplementary Data 3) and
differential methylation 189 CpG sites (FDR ≤0.05, Supplemen-
tary Data 4) (Fig. 4c). There was weak evidence that these
Table 1 Gene sets analysis of differentially expressed and methylated genes in activated vs. quiescent T cells
RNA-seq
Gene set NGenes Direction P value FDR
E2F_TARGETS 213 Up 0.00 0.00
MYC_TARGETS_V1 215 Up 0.00 0.00
MTORC1_SIGNALING 202 Up 0.00 0.00
G2M_CHECKPOINT 196 Up 0.00 0.00
MYC_TARGETS_V2 54 Up 0.00 0.00
OXIDATIVE_PHOSPHORYLATION 219 Up 0.00 0.00
FATTY_ACID_METABOLISM 147 Up 0.00 0.00
GLYCOLYSIS 191 Up 0.00 0.00
UNFOLDED_PROTEIN_RESPONSE 109 Up 0.00 0.00
DNA_REPAIR 158 Up 0.00 0.00
CHOLESTEROL_HOMEOSTASIS 75 Up 0.00 0.00
ADIPOGENESIS 195 Up 0.00 0.00
IL2_STAT5_SIGNALING 205 Up 0.00 0.00
TNFA_SIGNALING_VIA_NFKB 201 Up 0.00 0.00
HYPOXIA 189 Up 0.00 0.00
APOPTOSIS 165 Up 0.00 0.00
REACTIVE_OXIGEN_SPECIES_PATHWAY 50 Up 0.00 0.00
UV_RESPONSE_UP 169 Up 0.00 0.00
INTERFERON_GAMMA_RESPONSE 245 Up 0.00 0.00
PEROXISOME 92 Up 0.00 0.00
DNA methylation
Gene sets NGenes DM P value FDR
APOPTOSIS 161 6 0.01 0.06
MITOTIC_SPINDLE 200 7 0.01 0.05
COMPLEMENT 200 7 0.01 0.05
HEME_METABOLISM 200 7 0.01 0.05
PI3K_AKT_MTOR_SIGNALING 105 5 0.01 0.05
TGF_BETA_SIGNALING 54 4 0.00 0.03
IL2_STAT5_SIGNALING 200 8 0.00 0.03
INFLAMMATORY_RESPONSE 200 9 0.00 0.01
TNFA_SIGNALING_VIA_NFKB 200 10 0.00 0.00
ALLOGRAFT_REJECTION 200 10 0.00 0.00
UV_RESPONSE_DN 144 10 0.00 0.00
DM: differentially methylated; FDR: false discovery rate, P value
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activation-induced genomic changes were explained by pre-
existing differences in gene expression (two genes, FDR ≤0.05) or
DNA methylation (2 CpG, FDR ≤0.05) when comparing
quiescent cells between cases and controls (Supplementary
Table 3). This indicated that, in general, the basal state of resting
naive T cells was similar between the groups, but they largely
differed in their capacity to invoke the T cell activation program.
In support of this, we found that these signatures of food allergy
partially overlap T cell activation pathways, as 228/1412 (16%) of
the food allergy genes, and 33/156 (21%) of the food allergy CpGs
were also identiﬁed in the previous analysis of T cell activation.
In the activated T cells, there were far more differentially
expressed genes compared with differentially methylated CpG
sites (Fig. 4c). A striking feature of these data was the over-
representation of differentially expressed genes on chromosome
19 (Fig. 4c) that were highly enriched for C2H2-like family of zinc
ﬁnger proteins (Interpro: IPR015880, adjusted P= 1.6 × 10−57),
which were down-regulated in activated T cells in the allergic
group. This family includes DNA-binding TFs with known
functions in T cell development (BCL11B23) and T cell
exhaustion24. Gene sets testing revealed that targets of the E2F
and MYC TF networks and genes involved in the G2/M cell cycle
checkpoint transition were down-regulated among children with
food allergy (Table 2). Concomitantly, pathways related to
structural components of the cell cytoskeleton involved in the
contractile response (myogenesis, apical junction, epithelial
transition), signal transduction (STAT and WNT signaling),
and fatty acid metabolism (cholesterol homeostasis) were
signiﬁcantly upregulated. Taken together, these data delineate a
relationship between reduced expression of cell cycle genes, signal
transduction, and metabolic gene response programs.
Among the 189 differentially methylated sites identiﬁed in
case–control comparisons of activated T cells, we observed that
food allergy was associated with substantial loss of methylation at
89% of these sites (169/189), and gain of methylation at 11% (20/
189) CpG sites. Loss of methylation was localized to 112 unique
genes, with multiple hits observed in some genes (CDK6, GPR55,
RAD51L1, RPTOR, CD96, XXYLT1; Supplementary Data 4). Gain
of methylation was localized to 14 unique genes (Supplementary
Data 4). Differential methylation was enriched within the gene
body rather than promoters or CpG islands (Supplementary
Figure 4). We downloaded publicly available DNAse hypersensi-
tivity and ChIP-seq data from the ENCODE consortium from
CD4+ naive and effector/memory T cell populations to
determine whether allergy-associated differentially methylated
regions (allergy-dmrs) were enriched at lineage-deﬁning active
chromatin regions. We also included data from monocytes as a
negative control. We found that allergy-dmrs were enriched
within regions of accessible chromatin in effector T cells and
depleted in regions of accessible chromatin in naive T cells and
monocytes (Supplementary Figure 5). ChIP-seq data supported
this as allergy-dmrs were enriched for activating marks
(H3K4me1, H3K27ac) in effector/memory cells relative to naive
cells (Fig. 4d). Integrative analysis of methylation and gene
expression data sets revealed that differentially methylated CpG
sites were generally anti-correlated with changes in gene
expression (Fig. 4e), and by comparing overlaps between
differentially methylated and expressed data sets, we identiﬁed a
core set of 24 “differentially remodeled” genes, indicative of those
that had undergone a state change toward a more stable
expression proﬁle (Table 3). Of particular interest among these
were genes involved in the metabolic regulation of oxidative
phosphorylation and glycolysis (RPTOR, PIK3D, MAPK1,
FOXO1) and inﬂammatory genes (IL1R, IL18RAP, CD82), which
were upregulated in the allergics (Fig. 4e). In contrast, the Lck-
interacting transmembrane adapter 1 (LIME1) transcript, which
encodes an adaptor protein that links T cell receptor stimulation
to its downstream signaling pathway, was hyper-methylated and
suppressed in the allergics (Fig. 4e).
Polymorphisms at speciﬁc loci do not inﬂuence methylation.
Given previous published evidence that food allergy-associated
dmrs can mediate the effect of genetic variation5, we sought to
determine whether our differentially remodeled T cell activation
genes might be driven by local polymorphism. To do this, we
analyzed single-nucleotide polymorphism (SNP)-array data
available for 42 individuals (14 cases and 28 controls) in this
Table 2 Gene sets analysis of differentially expressed and methylated genes in allergics vs. controls at baseline
RNA-seq
Gene set NGenes Direction P value FDR
E2F_TARGETS 213 Down 0.00 0.00
G2M_CHECKPOINT 196 Down 0.00 0.00
MYC_TARGETS_V1 215 Down 0.00 0.03
SPERMATOGENESIS 104 Down 0.09 0.22
MYOGENESIS 151 Up 0.00 0.01
APICAL_JUNCTION 185 Up 0.00 0.03
CHOLESTEROL_HOMEOSTASIS 75 Up 0.00 0.03
TNFA_SIGNALING_VIA_NFKB 201 Up 0.01 0.03
WNT_BETA_CATENIN_SIGNALING 40 Up 0.01 0.03
IL2_STAT5_SIGNALING 205 Up 0.01 0.03
EPITHELIAL_MESENCHYMAL_TRANSITION 152 Up 0.01 0.03
UV_RESPONSE_UP 169 Up 0.01 0.03
DNA methylation
Gene set NGenes DM P value FDR
UV_RESPONSE_DN 144 10 0.00 0.00
TNFA_SIGNALING_VIA_NFKB 200 10 0.00 0.00
ALLOGRAFT_REJECTION 200 10 0.00 0.00
INFLAMMATORY_RESPONSE 200 9 0.00 0.01
IL2_STAT5_SIGNALING 200 8 0.00 0.03
TGF_BETA_SIGNALING 54 4 0.00 0.03
PI3K_AKT_MTOR_SIGNALING 105 5 0.01 0.05
DM: differentially methylated; FDR: false discovery rate, P value
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study and performed association testing of individual genotypes
and food allergy, and also computed linear regression models for
each SNP/gene and SNP/CpG pair. We limited our analysis to all
SNPs genotyped on the array within a heuristic 10-kb window up
and downstream of the core set of 24 differentially remodeled
genes25, as well as within genes encoding the de novo DNA
methyltransferase enzymes DNMT3A and DNMT3B and pre-
viously published food allergy SNPs annotated in the genome-
wide association study and SNPedia catalogs5,26. We also queried
the largest blood methylation quantitative trait loci (mQTL)
database27 for any SNPs that could potentially inﬂuence methy-
lation at the 24 genes of interest. In total, 87 high-quality SNPs
were tested for association with food allergy after adjusting for
ancestry using a heuristic un-adjusted P < 0.1 threshold. Of these,
3/87 SNPs in the RPTOR gene (rs9906827, rs2672886, rs9908768)
showed weak evidence of an association (P= 0.070, P= 0.047, P
= 0.093) with food allergy (Supplementary Table 4). This sug-
gested that patterns of differential methylation/gene expression at
RPTOR may be inﬂuenced by genetic risk variants. To determine
this, we tested for associations between SNP/gene pairs and SNP/
CpG pairs by extracting RPTOR transcripts and CpG methylation
levels from the corresponding data sets. We found no evidence
for an association between the three SNPs and RPTOR transcript
levels (rs9906827, P= 0.85; rs2672886, P= 0.56; rs9908768, P=
0.48). In total, 504 probes on the DNA methylation microarray
were annotated to RPTOR and we computed regression models
between SNP/CpG pairs generating 1512 P value associations. We
found evidence for six associations (FDR P value <0.05) indi-
cating that methylation patterns at these six loci were under the
inﬂuence of genetic variation. When we restricted this analysis to
just the food allergy-associated dmps in RPTOR (cg12592365,
cg00545580; Supplementary Data 4), we found no evidence for-
an association (Supplementary Figure 6), suggesting that
while local DNA methylation proﬁles at RPTOR may be inﬂu-
enced by genotype, we did not ﬁnd evidence that loss of
methylation at RPTOR associated with food allergy was sub-
stantially inﬂuenced by genetic variation within the SNPs tested
in this cohort.
Persistence of food allergy in childhood. Within this cohort, 26
of the egg allergic individuals (59% of cases) naturally acquired
tolerance to egg by the time they were assessed at follow-up. This
sample size was underpowered to identify genomic changes
associated with the development of clinical tolerance at the
genome-wide level, so this was not carried out. Rather, we per-
formed a longitudinal analysis of the loci associated with food
allergy at baseline to determine whether these changes were dif-
ferentially modiﬁed from baseline to follow-up. We performed
linear regression in the DNA methylation and gene expression
data sets separately, with phenotype at follow-up (persistent or
resolved) as the outcome variable, and DNA methylation/gene
expression as the predictor. We also assessed proliferative
responses and cytokine production.
We found that the majority of (24/26) loci associated with the
core set of “differentially remodeled” genes exhibited a statisti-
cally signiﬁcant (FDR ≤0.05, Table 4) change in DNA methyla-
tion from baseline to follow-up among children with persistent
food allergy, while epigenetic changes in the transient group were
stable (Fig. 5a). This suggested cumulative epigenetic disruption
and was associated with a trend for poorer lymphoproliferative
responses compared to children who resolved egg allergy (mean
resolved: 906,482, 95% CI: 466,333–1.34 × 106 vs. mean allergic:
395,375, 95% CI: −280,088 to 107 × 106) at follow-up (Fig. 5b).
Production of IFNγ was higher after activation among children
with persistent allergy (Fig. 5c).
Table 3 Differentially remodeled genes associated with food allergy at 12 months
DNA methylation Gene expression
ProbeID Chr Start Stop Deltabeta FDR Chr Start Stop Log FC FDR Gene
1 cg12592365 Chr17 78,765,948 78,765,949 −0.05 0.00 Chr17 78,518,619 78,940,171 0.439240548 0.00 RPTOR
2 cg02660643 Chr16 87,491,587 87,491,588 −0.05 0.00 Chr16 87,439,852 87,525,651 0.411181941 0.01 ZCCHC14
3 cg27403618 Chr1 209,907,350 209,907,351 −0.04 0.00 Chr1 209,859,510 209,908,295 1.342450486 0.04 HSD11B1
4 cg22152180 Chr1 172,558,180 172,558,181 −0.04 0.00 Chr1 172,501,489 172,580,971 −0.221601774 0.02 SUCO
5 cg26319797 Chr2 238,904,315 238,904,316 −0.03 0.00 Chr2 238,875,469 238,951,236 0.424532964 0.00 UBE2F
6 cg25298754 Chr3 111,314,102 111,314,103 −0.03 0.00 Chr3 111,311,747 111,314,290 0.919262265 0.03 ZBED2
7 cg09775648 Chr2 190,309,186 190,309,187 −0.05 0.01 Chr2 190,306,159 190,340,291 0.384026907 0.03 WDR75
8 cg22992505 Chr2 158,712,427 158,712,428 −0.04 0.01 Chr2 158,592,958 158732,374 0.295193799 0.05 ACVR1
9 cg00545580 Chr17 78,571,214 78,571,215 −0.05 0.01 Chr17 78,518,619 78,940,171 0.439240548 0.00 RPTOR
10 cg05175803 Chr11 44,597,119 44,597,120 −0.01 0.01 Chr11 44,585,977 44,641,913 0.445341065 0.01 CD82
11 cg24278087 Chr11 65,904,369 65,904,370 −0.03 0.01 Chr11 65,837,834 66,012,218 0.409525829 0.00 PACS1
12 cg16001422 Chr8 145,022,842 145,022,843 −0.04 0.02 Chr8 144,989,321 14,5050,902 0.554875897 0.02 PLEC
13 cg03116016 Chr16 15,583,606 15,583,607 −0.03 0.02 Chr16 15,528,152 15,718,885 0.920652897 0.01 C16orf45
14 cg25279613 Chr7 24,956,523 24,956,524 −0.06 0.02 Chr7 24,836,158 25,021,253 0.276014688 0.03 OSBPL3
15 cg00957665 Chr10 104,406,345 104,406,346 −0.01 0.02 Chr10 104,404,253 104,418,164 0.496130053 0.00 TRIM8
16 cg25867265 Chr1 66,737,176 66,737,177 0.06 0.03 Chr1 66,258,197 66,840,259 −0.443748368 0.05 PDE4B
17 cg20995327 Chr14 99,684,844 99,684,845 −0.03 0.03 Chr14 99,635,624 99,737,861 −0.250717631 0.04 BCL11B
18 cg17355385 Chr20 62,368,837 62,368,838 0.05 0.03 Chr20 62,366,815 62,370,456 −0.634130427 0.03 LIME1
19 cg20930706 Chr12 12,595,583 12,595,584 −0.02 0.03 Chr12 12,510,013 12,619,840 0.347785134 0.01 LOH12CR1
20 cg14174367 Chr1 202,128,508 202,128,509 −0.03 0.04 Chr1 202,116,141 202,130,716 0.239397286 0.05 PTPN7
21 cg24323726 Chr3 111,314,186 111,314,187 −0.03 0.04 Chr3 111,311,747 111,314,290 0.919262265 0.03 ZBED2
22 cg21410897 Chr2 69,735,185 69,735,186 −0.02 0.04 Chr2 69,688,532 69,901,481 0.284488561 0.03 AAK1
23 cg11903019 Chr6 154,560,711 154,560,712 −0.01 0.04 Chr6 154,475,631 154,677,926 −0.471902349 0.01 IPCEF1
24 cg04599190 Chr5 66,306,763 66,306,764 −0.02 0.04 Chr5 65,892,176 66,465,423 0.382960527 0.01 MAST4
25 cg10502206 Chr2 145,182,344 145,182,345 −0.02 0.04 Chr2 145,141,648 145,282,147 0.778825531 0.05 ZEB2
26 cg15928524 Chr17 17,599,543 17,599,544 −0.04 0.05 Chr17 17,584,787 17,714,767 0.312294786 0.02 RAI1
FDR: false discovery rate P value
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Discussion
Allergic diseases are thought to arise due to complex
gene–environment interactions impacting upon normal immune
development28, and reduced or altered functional capacity of T
cell responses is a consistently observed manifestation of the
atopic phenotype13,29,30. Our results indicate that naive T cells
from children with food allergy, although they appear immuno-
competent in relation to IL-2 production, exhibit an intrinsic
molecular defect during the early state of priming, and depressed
capacity for proliferation. Previous studies have speculated that
this may be attributed to intrinsic defects in T cells themselves, or
reduced/altered functional capacity of accessory cells such as
dendritic cells that prime T cell responses31. In the current study,
we isolated a homogenous population of antigen-naive CD4+
T cells and activated them independently of accessory cells under
non-polarizing conditions. Our data are consistent with an
intrinsic defect in naive T cells that is widespread and polyclonal
in nature, and likely reﬂects the different kinetics or trajectory of
normal immune development in allergic disease.
Activated T cells reprogram speciﬁc metabolic and mitotic
gene networks that are subsequently reﬁned by epigenetic mod-
iﬁcations32. Our analysis of the epigenetically regulated tran-
scriptional response points to gene networks activated via E2F
and MYC, and mTOR metabolic programs as markedly altered in
children with food allergy and delineates these as key pathways
modiﬁed by gene–environment interactions. These TFs integrate
activating and inhibitory signals to mediate thresholds of
activation21,33, transforming quiescent T cells into highly mitotic
proliferating cells. In addition, the striking over-representation of
zinc ﬁnger genes of the highly conserved C2H2 class on
chromosome 19 emerged as the strongest enrichment signal
among the list of down-regulated genes in the allergics. This
family of TFs preferentially recognize methylated DNA acting
mostly as chromatin-modulating transcriptional repressors of
methylated DNA templates34. The signiﬁcance of this ﬁnding is
unclear. One previous study also reported differential expression
of the C2H2 transcription factors between memory and exhaus-
ted CD8+ T cells24. We did not see evidence of upregulation of
classical inhibitory markers associated with T cell exhaustion.
This ﬁnding may therefore reﬂect a lack of coordinated tran-
scriptional regulation of quiescence genes.
These ﬁndings extend our previous work reporting on atte-
nuated lymphoproliferative responses in bulk CD4+ cells from
the cord blood of children with IgE-mediated food allergy11, and
conﬁrms that maturational defects in TCR signaling extend to
naive CD4+ T cell precursors. These and other recent data from
cord blood studies of immune function in children who develop
IgE food allergy9,12,35 imply that faulty immune development
precedes the clinical manifestation of disease and is clearly
important in disease etiology. How the molecular changes
described here are related to the maturation and development of
postnatal immune responses to allergens, or the development of
functionally unique pathogenic subtypes of allergen-reactive
T cells16 is unclear, and needs to be the focus on ongoing
investigation. A key ﬁnding from our study was that differential
methylation associated with food allergy was enriched at lineage-
deﬁning regions of open chromatin in effector and memory
T cells (Figure S5) and overlapped activating histone marks in
terminally differentiated T cell phenotypes (Fig. 4d). This implies
that changes in DNA methylation levels seen in allergic children
Table 4 Longitudinal analysis of differentially remodeled genes
ProbeID Chr Pos Persistent allergics (n= 49) Transient allergics (n= 115) Gene
Deltabeta
(FU-BL)
Adj.P value
deltabeta
Log FC
(FU-BL)
Adj. P
value
log FC
Deltabeta
(FU-BL)
Adj. P value
deltabeta
Log FC
(FU-BL)
Adj. P.
val
log FC
cg20995327 Chr12 12,595,583 0.172 0.000 −0.248 0.178 0.025 0.051 0.145 0.296 LOH12CR1
cg22152180 Chr2 238,904,315 0.079 0.000 0.134 0.536 0.026 0.095 0.125 0.296 UBE2F
cg09775648 Chr3 111,314,102 0.115 0.000 −0.179 0.611 0.058 0.095 −0.425 0.001 ZBED2
cg26319797 Chr2 190,309,186 0.148 0.000 −0.529 0.012 0.030 0.095 −0.114 0.467 WDR75
cg24278087 Chr11 44,597,119 0.072 0.000 −0.196 0.428 0.014 0.101 −0.088 0.591 CD82
cg05175803 Chr17 78,765,948 0.136 0.000 −0.230 0.323 0.025 0.141 −0.154 0.390 RPTOR
cg27403618 Chr1 209,907,350 0.078 0.000 −0.549 0.428 0.027 0.160 −0.213 0.627 HSD11B1
cg12592365 Chr16 15,583,606 0.100 0.000 −0.408 0.345 0.042 0.160 −0.075 0.612 C16orf45
cg02660643 Chr2 69,735,185 0.097 0.000 0.023 0.931 0.016 0.160 −0.033 0.758 AAK1
cg14174367 Chr17 17,599,543 0.085 0.001 −0.189 0.428 0.027 0.197 −0.289 0.001 RAI1
cg25279613 Chr8 145,022,842 0.056 0.001 0.245 0.498 0.029 0.197 −0.104 0.467 PLEC
cg17355385 Chr2 158,712,427 0.068 0.001 0.030 0.931 −0.022 0.245 −0.089 0.758 ACVR1
cg20930706 Chr1 172,558,180 0.055 0.001 0.141 0.428 0.026 0.455 −0.071 0.607 SUCO
cg15928524 Chr3 111,314,186 0.055 0.001 −0.179 0.611 0.016 0.464 −0.162 0.296 ZBED2
cg00545580 Chr6 154,560,711 0.092 0.002 0.695 0.012 0.014 0.556 −0.075 0.612 IPCEF1
cg22992505 Chr20 62,368,837 −0.073 0.003 −0.059 0.931 0.011 0.568 −0.034 0.758 LIME1
cg03116016 Chr7 24,956,523 0.079 0.004 0.000 0.998 0.007 0.805 0.046 0.774 OSBPL3
cg24323726 Chr11 65,904,369 0.024 0.009 −0.181 0.428 −0.006 0.805 0.089 0.758 PACS1
cg04599190 Chr17 78,571,214 0.061 0.018 −0.230 0.323 0.002 0.805 −0.039 0.758 RPTOR
cg00957665 Chr14 99,684,844 0.029 0.019 0.049 0.850 0.005 0.805 −0.228 0.027 BCL11B
cg25867265 Chr2 145,182,344 0.034 0.023 −0.228 0.536 −0.005 0.805 0.295 0.106 ZEB2
cg11903019 Chr1 202,128,508 0.051 0.025 −0.428 0.006 −0.009 0.805 0.349 0.053 PTPN7
cg16001422 Chr16 87,491,587 0.026 0.029 0.255 0.323 0.004 0.876 −0.102 0.719 ZCCHC14
cg21410897 Chr10 104,406,345 0.033 0.040 −0.323 0.049 0.003 0.876 0.124 0.390 TRIM8
cg10502206 Chr5 66,306,763 0.007 0.384 −0.168 0.464 0.002 0.896 −0.081 0.758 MAST4
cg25298754 Chr1 66,737,176 0.015 0.469 0.624 0.018 −0.001 0.999 0.089 0.758 PDE4B
Change in DNA methylation (deltabeta) and gene expression (log FC) from baseline to follow-up are shown
BL: baseline; FU: follow-up
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during naive T cell activation may alter T cell fate decisions,
which may skew T cell phenotypes at a very early point, but this
requires more detailed investigation.
Our study adds to the growing body of literature describing
epigenetic disruption in cow’s milk allergy4,36–38 and peanut
allergy39,40. The question of whether our data reﬂect the genetic
atopic predisposition is an important one since historical studies
clearly show that atopy affects postnatal maturation of T cell
competence13. We note that 18% of our cases had a reported
family history of food allergy, and thus we made use of available
SNP-array genotyping data to perform an association analysis on
a limited number of “modiﬁed” food allergy genes, but did not
ﬁnd strong evidence to suggest that genetic variation in these
genes was driving changes in DNA methylation. Moreover, the
longitudinal analysis suggests the accumulation of epigenetic
change throughout childhood uniquely among the group of
children who failed to resolve food allergy, which would be
inconsistent with genetic effects on methylation that are reported
to be fairly stable over time27. This should be interpreted cau-
tiously and in the context of limited study power, as extensive
investigation of the effect of genetic atopic predisposition on the
epigenetic regulation of gene expression was beyond the scope of
this study. Large comprehensive studies are needed to fully
address this. We did not detect differences in the patterning of
DNA methylation or gene expression in quiescent cells that might
explain the altered T cell responsiveness seen in the food allergic
infants. This might suggest that other epigenetic or post-
translational modiﬁcations are relevant.
Our study has several strengths. We started with a homo-
genous population of naive CD4+ T cells from a very well-
characterized cohort of infants with diagnostic food challenge
outcomes. We examined T cell function using a highly standar-
dized protocol across multiple resolutions of the genome, tran-
scriptome, and epigenome. Combining these data enabled new
insights into the transcriptional and epigenetic basis of T cell
hypo-responsiveness. The longitudinal design allowed us to
determine that the pathways described here were continually
modiﬁed in children whom failed to resolve food allergy.
Limitations included relatively small sample size. We were also
unable to include a cell division tracking dye into the ﬂow
cytometry antibody panels, and therefore unable to accurately
assess the number of cell divisions occurring in the 72 h following
activation or run detailed time-course experiments. In addition,
cell death was assessed by Trypan blue staining rather than
markers of apoptosis such as Annexin-V. Our study is not able to
address the question of whether T cell activation is suboptimal in
antigen-speciﬁc naive T cell populations, although we speculate
that this is the case. Future studies should seek to address the
epigenetic status of allergen-speciﬁc clones using peptide epitopes
loaded onto major histocompatibility complex class II tetramers.
In summary, this study revealed that food allergy in infancy is
associated with naive T cell hypo-responsiveness to activation,
which is related to epigenetic changes in metabolic and immu-
nological genes. Studies are now required to determine whether
the pathways identiﬁed here inﬂuence T cell fate decisions and
may skew the naive T cell response at an early time-point, pre-
disposing to the development of pathogenic CD4+ T cell subsets.
Methods
Study population and clinical data collection. Subjects were participants in the
population-based HealthNuts cohort study41–43 recruited through community
immunization clinics, and clinically assessed at the Royal Children’s Hospital in
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Melbourne, Australia, with informed consent and approved by the Royal Chil-
dren’s Human Research Ethics Committee (ref. no. 27047). All subjects were aged
between 11 and 15 months at the time of initial assessment (baseline), and
underwent skin prick testing to egg white, peanut, sesame, and one of two other
foods (cow’s milk or shrimp) and oral food challenges (OFCs) using predetermined
challenge criteria42. Allergic subjects (n= 44) were selected for this sub-study if
they were mono-sensitized and clinically reactive to egg at 12 months of age
(baseline), while age-matched controls (n= 21) were non-atopic to any of the
allergens tested. The allergic group subsequently returned for follow-up clinical
assessments at 2 or 4 years of age using identical criteria, at which time 26/44 (59%)
children had outgrown their egg allergy, clinically deﬁned as “transient egg allergy
“while 18/44 (41%) remained allergic (denoted as “persistent egg allergy”). Blood
was collected into a sodium heparin tube (Sarstedt, Inc, Newton, NC, USA) 1–2 h
after the OFC and peripheral blood mononuclear cells (PBMCs) puriﬁed using
Ficoll-Paque density gradient centrifugation within 2 h of blood collection. PBMCs
were viably cryopreserved for later experimentation. Biospecimens were main-
tained by the Melbourne Children’s Bioresource Centre with facility staff carrying
out sample processing, tracking, and long-term liquid nitrogen storage following
international best practice.
Isolation, activation, and expansion of naive CD4+ T cells. Cell cultures were
set up in a blinded fashion. Viable total CD4+ T cells were identiﬁed, Tregs (CD3
+CD4+CD25+CD127−) were excluded and naive CD4+ T cells (CD3+CD4
+CD25−CCR7+CD127−) were puriﬁed by ﬂow cytometry. To do this, PBMCs
were ﬁrst thawed using warm RPMI media (Sigma-Aldrich) supplemented with
10% heat-inactivated fetal calf serum (FCS) (HyClone), centrifuged at 500 × g and
washed twice before viability assessment by Trypan blue on the TC20 automated
cell counter (Bio-Rad). Mean PBMC viability was 87% across all subjects, 82%
across allergic subjects, 86% across non-allergic controls, and 89% across resolved
allergics. Cell pellets were resuspended at 1 × 106/ml in phosphate-buffered saline
(PBS) and 0.5 µl of ﬁxable viability stain 510 (BD Biosciences) added per ml of cell
suspension. Cells were incubated at room temperature for 15 min protected from
light, washed twice in FACS buffer (2% FCS, 2 mM EDTA in PBS), and resus-
pended in 50 µl FACS buffer for antibody staining. The antibody cocktail used to
deﬁne naive T cells included CD3-APCH7, CD4-A700, CD25-PE, CD127-V450,
CCR7-PECF954, and CD45RA BV711. All antibodies and isotype controls were
purchased from BD Biosciences (Australia). Cell sorting was performed using an
Inﬂux Cell Sorter (BD Biosciences). Ex vivo viable naive CD4+ T cells were seeded
in 96-well round bottom plates at a density of 8 × 104 cells per well in a total
volume of 200 µl of RPMI media supplemented with 10% FCS, 100 U/ml
penicillin–streptomycin, and 2mM L-glutamine+ rhIL-2 (200 U/mL, Life Tech-
nologies). T cells were divided into half and either activated with 2 µl of Human T
cell activator CD3/CD28 Dynabeads (Thermo Fisher Scientiﬁc) per well (1:1 ratio
bead-to-cell) or left resting in media alone for 72 h at 37 °C and 5% CO2. At culture
end-point, cells were thoroughly resuspended and magnetic beads removed prior to
obtaining cell and viability counts by Trypan blue exclusion on the TC20 auto-
mated cell counter. T cell proliferation was determined as the magnitude of the
difference between stimulated and un-stimulated control wells at 72 h.
Isolation and quantitation of nucleic acids. At termination of cultures, activated
and resting cells were recovered and centrifuged at 500 × g for 5 min in RPMI
media and cell pellets lysed in 350 µl of RLT buffer from the Qiagen AllPrep DNA/
RNA Extraction Micro Kit (Qiagen). Genomic DNA and total RNA were extracted
according to the manufacturer’s instructions using the QIACube automated liquid
handling robot (Qiagen). DNA and RNA were quantiﬁed on the Qubit ﬂourometer
using the Qubit dsDNA Broad Range Kit or the Qubit hsRNA Kit (Thermo Fisher
Scientiﬁc).
Quantitation of secreted cytokines. Cell culture supernatants were harvested and
frozen at −80 °C for later quantiﬁcation of TNF, IL-2, IFN-γ, IL-10, IL-6, IL-4, and
IL-17A by cytometric bead array (Human Th1/Th2/Th17 Kit, BD Biosciences)
according to the manufacturer’s instructions. CBA data were acquired on an LSR II
X-20 Fortessa (BD Biosciences) and analyzed using the LEGENDplex software
(BioLegend). The limits of detection for all assays was 20 pg/ml. Sample values
below the limit of detection (LOD) were set to LOD/2.
Genome-wide proﬁling of DNA methylation. Genomic DNA (200 ng) from
patient naive T cell samples were randomized and sent to Service XS (Netherlands)
for sodium bisulﬁte treatment and genome-wide methylation analysis using Illu-
mina InﬁniumMethylationEPIC BeadChips, which enables methylation measures
at over 850,000 CpG sites. Raw.iDAT ﬁles were preprocessed using the Minﬁ
package44 from the bioconductor project (http://www.bioconductor.org) in the R
statistical environment (http://cran.r-project.org/, version 3.3.0). Sample quality
was assessed using control probes on the array with one sample removed due to
poor assay performance. Between-array normalization was performed using the
stratiﬁed quantile method to correct for Type 1 and Type 2 probe bias45. Probes
exhibiting a P-detection call rate of >0.01 in 1 or more samples were removed
(14,036 probes) prior to analysis. Probes containing SNPs at the single base
extension site, or at the CpG assay site were removed, as were probes measuring
non-CpG loci (32,445 probes). Probes reported to have off-target effects in
McCartney et al.46 were also removed (39,690). After sample and probe ﬁltering the
ﬁnal data set size was 210 samples and 780,665 probes. Methylation percentages
were derived as β values with log 2 transformation to M values for statistical
analysis47. Batch correction was applied to M values using the ComBAT function
in the SVA package48.
RNA-sequencing. Total RNA was randomized and sent to the Translational
Genomics Unit—Sequencing Service and Development Platform at the Murdoch
Children’s Research Institute/Victorian Clinical Genetics Services for next-
generation sequencing. Library preparation was performed using the Illumina
TruSeq Stranded mRNA Kit with a starting input of 50 ng and libraries were
sequenced on the Illumina HiSeq 4000 instrument generating an average of 20
million reads per sample. Fastq ﬁles were assessed for quality using the FastQC
package49 and no samples were excluded from analysis. The Salmon aligner
(v0.8.2,50) was used to map 75-bp paired-end reads to the human transcriptome
(Ensembl, GRCh37v75). Uniquely mapped reads were summarized across all genes
with the tximport program51. Genes not highly expressed were ﬁltered out (<10
counts per million), and multidimensional scaling analysis was used to assess
sample quality during which two samples were removed leaving a ﬁnal data set size
of 18,864 genes and 134 samples. The count data were TMM normalized52 and
voom transformed prior to statistical analysis53.
Genotyping. Existing SNP-array genotyping data were available for subjects in this
study as part of a previous investigation into the genetic determinants of food
allergy54. These individuals were genotyped on the Illumina Human Omni2.8v8
array. Individuals were excluding if sample call rates were <95%. SNPs were
excluded if call rates were <95% or allele frequencies were <5% or failed the test for
Hardy–Weinberg equilibrium (P < 0.001) or had signiﬁcant (P < 0.001) differential
missingness between cases and controls. In total 42/65 individuals in this study had
high-quality genotype data available. SNPs were selected for association testing by
virtue of being annotated to a heuristic ± 10 kb window of the food allergy genes of
interest, or within the de novo DNA methyltransferase enzymes, proving coverage
across the entire gene sequence25. The number of SNPs covering each gene can be
found in Table S6. For selecting SNPs previously associated with food allergy in
SNPedia, we used proxies annotated in the SNAP database55 with an r2 cut-off of
0.5 that were genotyped on the Omni array and passed QC. We also queried the
AIRES GCTA database27 across all time points using the default trans distance of 1
Mb for potential mQTLs and selected proxies using SNAP. Case–control asso-
ciation testing was carried out in PLINK56 under an additive model, adjusting for
ancestry, with Bonferroni correction applied to limit Type 1 error. Ancestry vari-
ables (Caucasian, non-Caucasian) were derived from parent report and validated
by genetic inference using identity-by-state analysis and visual inspection of
multidimensional scaling analysis of all individuals and reference individuals from
the 1000 Genomes project54.
Statistical analysis. The statistical analysis for this study was pre-registered with
the Center for Open Science (https://osf.io/pys9e/register/
565fb3678c5e4a66b5582f67) and the project is deposited in the Open Science
Framework repository (https://doi.org/10.17605/OSF.IO/HBWRE). For hypothesis
testing (differential analysis) of methylation and gene expression data, a factorial
regression model was ﬁtted to the data with adjustment variables for batch (ﬂow
cell or chip position), sex, ancestry, eczema status, and the ﬁrst seven PCs. As this
was a repeated-measures design, each subject was treated as a random effect. Cross-
sectional comparisons were made at baseline and follow-up, and for the long-
itudinal analysis we constructed a model that included main effects for treatment
(activated or quiescent), time, allergy status, and ﬁtted an interaction term for
time × allergy status. All between-group comparisons were made using moderated t
tests from the R Bioconductor limma package57. Evidence for differential methy-
lation/expression was declared when false discovery corrected P values were 0.05 or
lower. For comparisons of activated vs. quiescent T cells, we applied an additional
threshold ﬁlter to remove genes with a log fold change <1.5. We used QQ plots and
calculated the genomic inﬂation (lambda) factor to determine how well the model
ﬁt the data and to check for any potential sources of bias, and these data are
provided in Supplementary Figure 7. For integrated analysis of differentially
methylated loci and gene expression, genomic coordinates of differentially
methylated probes mapping to human genome build 19 (hg19) were extracted from
the manufacturer's annotation ﬁle using the “getAnnotation” function in the Minﬁ
R package. For gene expression, ENSMBL transcript ID’s were mapped to hg19
using the org.Hs.eg.db in Bioconductor. The resulting genomic coordinates and
differential analysis statistics were converted to GRanges objects and the data sets
were merged by overlapping coordinates using the “mergeByOverlaps” function in
the IRanges r package58. Gene set testing was carried out using the Camera
competitive test accounting for inter-gene correlation using 0.01 as input para-
meter59. Publicly available ChIP-seq and DNAse1 accessibility data were down-
loaded from the ENCODE60 and ROADMAP61 consortiums. Enrichment analysis
of these data were carried out using the Genomic Hyperbrowser GSUITE of tools.
A suite of tracks representing different genomic features for a speciﬁc cell type were
selected from the ENCODE repository. To determine which tracks in the suite
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exhibit the strongest similarity by co-occurrence to experimentally determined
regions of differential methylation, the Forbes coefﬁcient was used to obtain
rankings of tracks, and Monte Carlo simulations were used to deﬁne a statistical
assessment of the robustness of the rankings using randomization of genomic
regions covered by the EPIC array to derive a null model, and compute test
statistics62,63. Methylation and expression QTL analysis was performed using the
Matrix eQTL R package64 under a linear additive model and a homoscedastic error
covariance matrix.
Data availability. The data sets generated and analyzed for the current study are
deposited in the Gene Expression Omnibus repository with the primary accession
code GSE114135.
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